End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2024 * | 301M 411M | Sales 2025 * | 334M 456M | Capitalization | 965M 1.32B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 3.83 x |
Net Debt 2024 * | 187M 256M | Net Debt 2025 * | 106M 145M | EV / Sales 2025 * | 3.21 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 65.34% |
Latest transcript on Theravance Inc
Managers | Title | Age | Since |
---|---|---|---|
Pavel Raifeld
CEO | Chief Executive Officer | 40 | 20-05-19 |
Stephen Basso
DFI | Director of Finance/CFO | 58 | 23-08-20 |
Marianne Zhen
AUD | Comptroller/Controller/Auditor | 55 | 14-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 64 | 18-02-11 | |
Director/Board Member | 53 | 22-12-31 | |
Jules Haimovitz
BRD | Director/Board Member | 73 | 18-02-11 |
1st Jan change | Capi. | |
---|---|---|
+25.93% | 661B | |
+26.74% | 566B | |
-6.65% | 352B | |
+19.38% | 332B | |
+3.37% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.15% | 145B |